Prelude Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.46M | Buy |
|
|||||
|
2024
Q4 | $1.13M | Sell |
|
|||||
|
2024
Q3 | $1.33M | Sell |
|
|||||
|
2024
Q2 | $1.2M | Sell |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2023
Q4 | $317K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $358K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $898K | Sell |
|
|||||
|
2021
Q2 | $1.35M | Sell |
|
|||||
|
2021
Q1 | $2M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $179K | Sell |
|
|||||
|
2020
Q2 | $306K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $59K | Sell |
|
|||||
|
2015
Q4 | $844K | Buy |
|
|||||
|
2015
Q3 | $568K | Sell |
|
|||||
|
2015
Q2 | $929K | Sell |
|
|||||
|
2015
Q1 | $848K | Buy |
|
|||||
|
2014
Q4 | $317K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $391K | Hold |
|
|||||
|
2013
Q3 | $390K | Sell |
|
|||||
|
2013
Q2 | $690K | Buy |
|